Back to Feed
总结
多家媒体报道，澳大利亚监管机构近日就疑似假冒抗狂犬病疫苗“Abhayrab”发布安全提示，称市场上出现与该产品相关的可疑批次并提醒医疗机构和公众核查来源。印度生产商Indian Immunologicals Ltd表示，所涉“假冒”疫苗并非其供应链产品，相关批次已不再有库存，并已向澳方提出复核或撤回警示的请求。与此同时，印度药品监管机构CDSCO截至报道时未公开回应。事件引发跨境药品监管协作与疫苗供应链追溯的关注，相关国家可能加强对进口渠道、批号核验和使用记录的排查，以降低接种风险并澄清影响范围。
正文
Abhayrab episode: Global regulators warn, CDSCO stays silent India Today UPSC Mains Current Affairs for 30 December 2025 Vajiram & Ravi Counterfeit of anti-rabies vaccine no longer in stock: Indian Immunologicals Ltd The Hindu Indian vaccine maker seeks review of Australian alert on counterfeit rabies shots Telegraph India Abhayrab rabies vaccine: Why Australia issued an advisory and how the Indian manufacturer responded MSN
发布时间：